Synjardy® 12.5mg/1000mg film-coated tablets

COMBINATION_PRODUCT2 trials

Sponsors

Humanis Saglık Anonim Sirketi, University Medical Centre Ljubljana

Conditions

Diabetes Type 2Type2diabetes

Phase 1

Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets

CompletedNCT06450262

Humanis Saglık Anonim SirketiType2diabetes

Start: 2024-01-04End: 2024-03-05Updated: 2024-06-10

Phase 4

The Effect of Empagliflozin and Metformin on Oxidative Capacity and Microvascular Reactivity of Skeletal Muscle in Patients With Type 2 Diabetes Mellitus

RecruitingNCT07771010

University Medical Centre LjubljanaDiabetes Type 2

Start: 2026-04-16End: 2028-07-31Target: 54Updated: 2026-08-18